Vanderbilt Ingram Cancer Center
-
Metastatic pancreatic cancer ‘reprograms’ for malignancy
Metastatic pancreatic cancer — cancer that has spread from the pancreas to other tissues and is responsible for most patient deaths — changes its metabolism and is “reprogrammed” for optimal malignancy, according to new findings reported Jan. 16 in Nature Genetics. Read MoreJan 19, 2017
-
Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts
Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. Read MoreJan 17, 2017
-
Morton to help lead blood disorders treatment efforts
Colleen Morton, M.D., has joined Vanderbilt University Medical Center (VUMC) as section chief of Classical Hematology, a specialty also known as “benign hematology” because it covers all blood disorders that are not cancer. Read MoreJan 12, 2017
-
Team’s discovery offers new insight on lung cancer risk
Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts. Read MoreJan 12, 2017
-
Midgut neuroendocrine tumor prognosis
Vanderbilt investigators recommend that the presence of tumor deposits in the abdomen be included when staging midgut neuroendocrine tumors. Read MoreJan 6, 2017
-
VICC initiative seeks to provide comfort for cancer patients
Finn Schafran has always been a happy child, but these days the nearly 2-year-old boy is adjusting to spending part of each day at Vanderbilt-Ingram Cancer Center (VICC), where he receives chemotherapy and radiation for a rare cancer. Read MoreJan 5, 2017
-
Moses elected to National Academy of Inventors
Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has been named a Fellow of the National Academy of Inventors (NAI). Moses, professor and interim chair of Cancer Biology, is among 175 academic leaders named to the 2016 class of NAI Fellows. Read MoreDec 16, 2016
-
Ozgener family responds to cancer by supporting research
Nashville entrepreneur-turned-artist Cano Ozgener and his family have repeatedly faced cancer and its consequences, but rather than feel embattled, they've chosen to respond by creating beauty to share with others and by actively supporting the mission of the Vanderbilt-Ingram Cancer Center (VICC). Read MoreDec 15, 2016
-
Vanderbilt mourns loss of philanthropist Tony Martell
Members of the Vanderbilt community are mourning the loss of music executive and health care philanthropist Tony Martell, who died Sunday, Nov. 27, at his home in New Jersey. He was 90. Read MoreDec 7, 2016
-
Rodriguez named Associate Nursing Officer at VICC
Forward is the only direction in which Anna Rodriguez likes to travel. Read MoreDec 1, 2016
-
V Foundation grants bolster cancer initiatives
Two Vanderbilt-Ingram Cancer Center (VICC) investigators have earned grant awards from The V Foundation for Cancer Research, continuing the foundation’s support for innovative cancer research initiatives at VICC. Read MoreNov 17, 2016
-
Study details rare heart risk of certain cancer therapies
Justin Balko, Pharm.D., Ph.D., seated, Javid Moslehi, M.D., left, and Douglas Johnson, M.D., MSCI, review data on rare cardiac side effects linked to cancer immunotherapy combination therapy. (photo by Susan Urmy) Combination therapy using two approved immunotherapy drugs for cancer treatment may cause rare and sometimes fatal cardiac side… Read MoreNov 3, 2016
-
Emerging field of cardio-oncology seeks better tools
Improved therapies have led to a spike in the number of people living with cancer, and today there are more than 15.5 million survivors in the United States. However, some of these therapies can cause toxicities to the heart, the vessels and the body’s metabolism. Read MoreOct 27, 2016
-
DNA damage response protein
Vanderbilt researchers have determined that a previously uncharacterized protein responds to DNA replication stress and has an essential role in maintaining the integrity of the genome. Read MoreOct 21, 2016
-
VICC trial putting lung cancer therapy to the test
Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis. Read MoreOct 20, 2016
-
Cancer disparities grant with Meharry, TSU gains renewal
A multi-year collaborative cancer research effort among Vanderbilt University Medical Center (VUMC), Meharry Medical College (MMC) and Tennessee State University (TSU) will receive continued federal funding through the renewal of U54 Partners in Eliminating Cancer Disparities Grants from the National Cancer Institute (NCI), a division of the National Institutes of Health. Read MoreOct 20, 2016
-
Screening mammograms now offered at four locations
One in eight women will be diagnosed with breast cancer in their lifetime and those cancers are often detected through screening mammograms. A mammogram is a low-dose X-ray of the breast that enables an imaging specialist to look for changes in breast tissue that could indicate cancer. Read MoreOct 13, 2016
-
Vanderbilt scientists to lead chronic disease research initiative in Vietnam
Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam. Read MoreOct 6, 2016
-
Annual cancer survivorship celebration slated for Nov. 6
Vanderbilt-Ingram Cancer Center’s 2016 Cancer Survivorship Celebration will be held Sunday, Nov. 6, from 2 to 4 p.m. The annual event is being hosted in partnership with Monroe Carell Jr. Children’s Hospital at Vanderbilt. Read MoreOct 4, 2016
-
VUMC’s Lehman lands LUNGevity research support
Jonathan Lehman, M.D., Ph.D., instructor in Medicine in the Division of Hematology/Oncology, has received a Career Development Award from LUNGevity, a nonprofit organization that provides support programs for lung cancer patients and families, public education and funding for innovative scientific research. Read MoreSep 22, 2016